BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 10502421)

  • 1. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
    Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
    Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC ameliorates ovarian cancer-associated inflammation.
    Said NA; Elmarakby AA; Imig JD; Fulton DJ; Motamed K
    Neoplasia; 2008 Oct; 10(10):1092-104. PubMed ID: 18813349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histomorphological Evaluation of Desmoplastic Tumor Stroma in Malignant Ovarian Surface Epithelial Tumors.
    Ahuja S; Zaheer S; Ranga S
    J Midlife Health; 2023; 14(2):107-111. PubMed ID: 38029034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonectin (SPARC) prognostic value in prostate cancer.
    Chekhun V; Borikun T; Zadvornyi T; Mushii O; Stakhovsky E; Vitruk Y; Lukianova N
    Pathol Res Pract; 2024 Feb; 254():155053. PubMed ID: 38199134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC: a potential target for functional nanomaterials and drugs.
    Jiang S; Sun HF; Li S; Zhang N; Chen JS; Liu JX
    Front Mol Biosci; 2023; 10():1235428. PubMed ID: 37577749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells.
    Yoshida S; Asanoma K; Yagi H; Onoyama I; Hori E; Matsumura Y; Okugawa K; Yahata H; Kato K
    BMC Cancer; 2021 Feb; 21(1):156. PubMed ID: 33579227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation.
    Dasari S; Pandhiri T; Grassi T; Visscher DW; Multinu F; Agarwal K; Mariani A; Shridhar V; Mitra AK
    Mol Cancer Res; 2020 Aug; 18(8):1202-1217. PubMed ID: 32350057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study.
    Liu Y; Dong Y; Zhu H; Jing W; Guo H; Yu J
    Cancer Med; 2020 Feb; 9(4):1365-1373. PubMed ID: 31876976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.
    Xing P; Zhu Y; Shan L; Chen S; Hao X; Li J
    Oncotarget; 2017 Oct; 8(50):87442-87454. PubMed ID: 29152093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.
    Tumbarello DA; Andrews MR; Brenton JD
    PLoS One; 2016; 11(9):e0162698. PubMed ID: 27622658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes.
    Villaruz LC; Socinski MA
    Eur J Cancer; 2016 Mar; 56():162-171. PubMed ID: 26875112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
    Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G
    Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.
    Chudecka-Głaz AM; Cymbaluk-Płoska AA; Menkiszak JL; Pius-Sadowska E; Machaliński BB; Sompolska-Rzechuła A; Rzepka-Górska IA
    Onco Targets Ther; 2015; 8():471-85. PubMed ID: 25750541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of SPARC expression in gastric cancer: a meta-analysis.
    Wang Z; Hao B; Yang Y; Wang R; Li Y; Wu Q
    Arch Med Sci; 2014 Oct; 10(5):863-9. PubMed ID: 25395936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the tumor stroma in ovarian cancer.
    Davidson B; Trope CG; Reich R
    Front Oncol; 2014; 4():104. PubMed ID: 24860785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel.
    Gupta N; Hatoum H; Dy GK
    Int J Nanomedicine; 2014; 9():209-21. PubMed ID: 24399877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in mice.
    Lopez MV; Rivera AA; Viale DL; Benedetti L; Cuneo N; Kimball KJ; Wang M; Douglas JT; Zhu ZB; Bravo AI; Gidekel M; Alvarez RD; Curiel DT; Podhajcer OL
    Mol Ther; 2012 Dec; 20(12):2222-33. PubMed ID: 22948673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.
    Chen J; Wang M; Xi B; Xue J; He D; Zhang J; Zhao Y
    PLoS One; 2012; 7(8):e42413. PubMed ID: 22879971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of Pax6 with SPARC and p53 in brain of mice indicates Smad3 dependent auto-regulation.
    Tripathi R; Mishra R
    J Mol Neurosci; 2010 Jul; 41(3):397-403. PubMed ID: 20177825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evolution of SPARC: absence of the acidic module and expression in the endoderm of the starlet sea anemone, Nematostella vectensis.
    Koehler A; Desser S; Chang B; MacDonald J; Tepass U; Ringuette M
    Dev Genes Evol; 2009 Oct; 219(9-10):509-21. PubMed ID: 20043230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.